Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review
Top Cited Papers
Open Access
- 7 August 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 104 (15) , 1134-1164
- https://doi.org/10.1093/jnci/djs285
Abstract
Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult’s medical, psychological, social, and functional capacity. No systematic review of the use of geriatric assessment in oncology has been conducted. The goals of this systematic review were: 1) to provide an overview of all geriatric assessment instruments used in the oncology setting; 2) to examine the feasibility and psychometric properties of those instruments; and 3) to systematically evaluate the effectiveness of geriatric assessment in predicting or modifying outcomes (including the impact on treatment decision making, toxicity of treatment, and mortality). We searched Medline, Embase, Psychinfo, Cinahl, and the Cochrane Library for articles published in English, French, Dutch, or German between January 1, 1996, and November 16, 2010, reporting on cross-sectional, longitudinal, interventional, or observational studies that assessed the feasibility or effectiveness of geriatric assessment instruments. The quality of articles was evaluated using relevant quality assessment frameworks. We identified 83 articles that reported on 73 studies. The quality of most studies was poor to moderate. Eleven studies examined psychometric properties or diagnostic accuracy of the geriatric assessment instruments used. The assessment generally took 10–45min. Geriatric assessment was most often completed to describe a patient’s health and functional status. Specific domains of geriatric assessment were associated with treatment toxicity in 6 of 9 studies and with mortality in 8 of 16 studies. Of the four studies that examined the impact of geriatric assessment on the cancer treatment decision, two found that geriatric assessment impacted 40%–50% of treatment decisions. Geriatric assessment in the oncology setting is feasible, and some domains are associated with adverse outcomes. However, there is limited evidence that geriatric assessment impacted treatment decision making. Further research examining the effectiveness of geriatric assessment on treatment decisions and outcomes is needed.Keywords
This publication has 113 references indexed in Scilit:
- Screening older cancer patients: first evaluation of the G-8 geriatric screening toolAnnals of Oncology, 2012
- Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessmentEuropean Journal Of Cancer, 2011
- Obese Frailty, Physical Performance Deficits, and Falls in Older Men with Biochemical Recurrence of Prostate Cancer on Androgen Deprivation Therapy: A Case-control StudyUrology, 2011
- Development of a cancer-specific Comprehensive Geriatric Assessment in a University Hospital in SpainCritical Reviews in Oncology/Hematology, 2011
- Assessment and treatment of elderly patients with cancerSurgical Oncology, 2010
- Identifying an accurate pre-screening tool in geriatric oncologyCritical Reviews in Oncology/Hematology, 2010
- Falls and Physical Performance Deficits in Older Patients With Prostate Cancer Undergoing Androgen Deprivation TherapyUrology, 2008
- Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology programCritical Reviews in Oncology/Hematology, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- A pilot study of the vulnerable elders survey‐13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablationCancer, 2007